Lung Cancer – Dana-Farber Cancer Institute Handbook

描述

Lung Cancer – Dana-Farber Cancer Institute Handbook
Edited by Arthur T. Skarin, MD, FACP, FCCP and Paul Lorigan, MB, FRCP

168 pages 152 ills
Trim size 5 1/5 X 7 7/8 in
Copyright 2007

Description
Written by highly eminent authors, Lung Cancer – a handbook in the Dana-Farber Cancer Institute series – is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, particularly the management of metastatic lung disease in the context of new and emerging treatments.

Key Features

Comprehensive coverage – from risk and prevention, and screening and diagnosis, through to treatment options (surgery, chemotherapy, radiation therapy, biological response modifiers)
Attractively designed aids with instant access to the information
Contains useful algorithms to aid management decisions
Discusses practical management of problems in cancer therapy including fever, vomiting, alopecia, fatigue, pain and cachexia
Provides practical advice regarding drug administration
Linked to the hugely successful Dana-Farber Atlas of Diagnostic Oncology
Table of Contents
Introduction
The role of molecular probes and other markers in the diagnosis and characterization of malignancy
Lung cancer: aetiology, histopathology and clinical manifestation
Lung cancer treatment
Systemic and mucocutaneous reactions to chemotherapy